# Curtiss Wright Corp: financial statements, quarterly

CW · NYSE · CIK 26324 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cw.md) · [Financials](/companies/cw/financials.md) · [Filings](/companies/cw/filings.md) · [Insiders](/companies/cw/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cw/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [724](/filings/0000026324-24-000048.md) | [786 d](/filings/0001628280-26-007587.md) | [713](/filings/0000026324-25-000023.md) | [785](/filings/0001628280-25-038802.md) | [799](/filings/0001628280-25-050106.md) | [824 d](/filings/0001628280-26-007587.md) | [806](/filings/0001628280-26-031971.md) | [877](/filings/0001628280-26-054196.md) | [869](/filings/0001628280-25-050106.md) | [947 d](/filings/0001628280-26-007587.md) | [914](/filings/0001628280-26-031971.md) | [924](/filings/0001628280-26-054196.md) |
| Cost of revenue | $m | [443](/filings/0000026324-24-000048.md) | [481 d](/filings/0001628280-26-007587.md) | [459](/filings/0000026324-25-000023.md) | [501](/filings/0001628280-25-038802.md) | [501](/filings/0001628280-25-050106.md) | [507 d](/filings/0001628280-26-007587.md) | [513](/filings/0001628280-26-031971.md) | [550](/filings/0001628280-26-054196.md) | [542](/filings/0001628280-25-050106.md) | [592 d](/filings/0001628280-26-007587.md) | [582](/filings/0001628280-26-031971.md) | [560](/filings/0001628280-26-054196.md) |
| Gross profit | $m | [281](/filings/0000026324-24-000048.md) | [305 d](/filings/0001628280-26-007587.md) | [254](/filings/0000026324-25-000023.md) | [284](/filings/0001628280-25-038802.md) | [298](/filings/0001628280-25-050106.md) | [317 d](/filings/0001628280-26-007587.md) | [292](/filings/0001628280-26-031971.md) | [326](/filings/0001628280-26-054196.md) | [327](/filings/0001628280-25-050106.md) | [355 d](/filings/0001628280-26-007587.md) | [331](/filings/0001628280-26-031971.md) | [364](/filings/0001628280-26-054196.md) |
| Research and development | $m | [23.5](/filings/0000026324-24-000048.md) | [20.1 d](/filings/0001628280-26-007587.md) | [23.0](/filings/0000026324-25-000023.md) | [22.2](/filings/0001628280-25-038802.md) | [20.7](/filings/0001628280-25-050106.md) | [25.8 d](/filings/0001628280-26-007587.md) | [23.0](/filings/0001628280-26-031971.md) | [23.3](/filings/0001628280-26-054196.md) | [23.4](/filings/0001628280-25-050106.md) | [25.4 d](/filings/0001628280-26-007587.md) | [24.2](/filings/0001628280-26-031971.md) | [25.1](/filings/0001628280-26-054196.md) |
| Operating income | $m | [133](/filings/0000026324-24-000048.md) | [161 d](/filings/0001628280-26-007587.md) | [100.0](/filings/0000026324-25-000023.md) | [129](/filings/0001628280-25-038802.md) | [145](/filings/0001628280-25-050106.md) | [155 d](/filings/0001628280-26-007587.md) | [129](/filings/0001628280-26-031971.md) | [156](/filings/0001628280-26-054196.md) | [166](/filings/0001628280-25-050106.md) | [182 d](/filings/0001628280-26-007587.md) | [160](/filings/0001628280-26-031971.md) | [179](/filings/0001628280-26-054196.md) |
| Interest expense | $m | [12.5](/filings/0000026324-24-000048.md) | [11.0 d](/filings/0000026324-24-000004.md) | [10.6](/filings/0000026324-25-000023.md) | [11.2](/filings/0000026324-24-000037.md) | [11.4](/filings/0001628280-25-050106.md) | [11.7 d](/filings/0001628280-26-007587.md) | [10.1](/filings/0001628280-26-031971.md) | [10.5](/filings/0001628280-26-054196.md) | [10.5](/filings/0001628280-25-050106.md) | [12.0 d](/filings/0001628280-26-007587.md) | [9.9](/filings/0001628280-26-031971.md) | [9.9](/filings/0001628280-26-054196.md) |
| Income tax | $m | [30.3](/filings/0000026324-24-000048.md) | [37.0 d](/filings/0001628280-26-007587.md) | [22.5](/filings/0000026324-25-000023.md) | [26.8](/filings/0001628280-25-038802.md) | [32.5](/filings/0001628280-25-050106.md) | [35.3 d](/filings/0001628280-26-007587.md) | [23.8](/filings/0001628280-26-031971.md) | [35.7](/filings/0001628280-26-054196.md) | [36.3](/filings/0001628280-25-050106.md) | [40.0 d](/filings/0001628280-26-007587.md) | [29.6](/filings/0001628280-26-031971.md) | [43.1](/filings/0001628280-26-054196.md) |
| Net income | $m | [96.8](/filings/0000026324-24-000048.md) | [120 d](/filings/0001628280-26-007587.md) | [76.5](/filings/0000026324-25-000023.md) | [99.5](/filings/0001628280-25-038802.md) | [111](/filings/0001628280-25-050106.md) | [118 d](/filings/0001628280-26-007587.md) | [101](/filings/0001628280-26-031971.md) | [121](/filings/0001628280-26-054196.md) | [125](/filings/0001628280-25-050106.md) | [137 d](/filings/0001628280-26-007587.md) | [128](/filings/0001628280-26-031971.md) | [151](/filings/0001628280-26-054196.md) |
| Diluted EPS | $ per share | [2.51](/filings/0000026324-24-000048.md) | not reported | [1.99](/filings/0000026324-25-000023.md) | [2.58](/filings/0001628280-25-038802.md) | [2.89](/filings/0001628280-25-050106.md) | not reported | [2.68](/filings/0001628280-26-031971.md) | [3.19](/filings/0001628280-26-054196.md) | [3.31](/filings/0001628280-25-050106.md) | not reported | [3.46](/filings/0001628280-26-031971.md) | [4.07](/filings/0001628280-26-054196.md) |
| Basic EPS | $ per share | [2.53](/filings/0000026324-24-000048.md) | not reported | [2.00](/filings/0000026324-25-000023.md) | [2.60](/filings/0001628280-25-038802.md) | [2.91](/filings/0001628280-25-050106.md) | not reported | [2.69](/filings/0001628280-26-031971.md) | [3.21](/filings/0001628280-26-054196.md) | [3.34](/filings/0001628280-25-050106.md) | not reported | [3.47](/filings/0001628280-26-031971.md) | [4.09](/filings/0001628280-26-054196.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue, us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [407](/filings/0000026324-24-000012.md) | [338](/filings/0000026324-24-000012.md) | not reported | not reported | [385](/filings/0000026324-25-000023.md) | [226](/filings/0000026324-25-000023.md) | not reported | not reported | [371](/filings/0001628280-26-031971.md) | [343](/filings/0001628280-26-031971.md) | not reported |
| Current assets | $m | [1,545](/filings/0000026324-23-000015.md) | [1,717](/filings/0000026324-25-000015.md) | [1,737](/filings/0000026324-24-000012.md) | [1,836](/filings/0000026324-24-000037.md) | [1,952](/filings/0000026324-24-000048.md) | [1,850](/filings/0001628280-26-007587.md) | [1,800](/filings/0000026324-25-000023.md) | [2,000](/filings/0001628280-25-038802.md) | [1,927](/filings/0001628280-25-050106.md) | [2,018](/filings/0001628280-26-054196.md) | [2,072](/filings/0001628280-26-031971.md) | [2,237](/filings/0001628280-26-054196.md) |
| Total assets | $m | [4,414](/filings/0000026324-23-000015.md) | [4,621](/filings/0000026324-25-000015.md) | [4,612](/filings/0000026324-24-000012.md) | [4,748](/filings/0000026324-24-000037.md) | [4,886](/filings/0000026324-24-000048.md) | [4,986](/filings/0001628280-26-007587.md) | [4,952](/filings/0000026324-25-000023.md) | [5,194](/filings/0001628280-25-038802.md) | [5,102](/filings/0001628280-25-050106.md) | [5,221](/filings/0001628280-26-054196.md) | [5,270](/filings/0001628280-26-031971.md) | [5,456](/filings/0001628280-26-054196.md) |
| Current liabilities | $m | [775](/filings/0000026324-23-000015.md) | [807](/filings/0000026324-25-000015.md) | [858](/filings/0000026324-24-000012.md) | [897](/filings/0000026324-24-000037.md) | [987](/filings/0000026324-24-000048.md) | [1,096](/filings/0001628280-26-007587.md) | [954](/filings/0000026324-25-000023.md) | [1,027](/filings/0001628280-25-038802.md) | [1,101](/filings/0001628280-25-050106.md) | [1,406](/filings/0001628280-26-054196.md) | [1,360](/filings/0001628280-26-031971.md) | [1,397](/filings/0001628280-26-054196.md) |
| Total liabilities | $m | [2,229](/filings/0000026324-23-000015.md) | [2,293](/filings/0000026324-25-000015.md) | [2,232](/filings/0000026324-24-000012.md) | [2,290](/filings/0000026324-24-000037.md) | [2,395](/filings/0000026324-24-000048.md) | [2,536](/filings/0001628280-26-007587.md) | [2,393](/filings/0000026324-25-000023.md) | [2,483](/filings/0001628280-25-038802.md) | [2,573](/filings/0001628280-25-050106.md) | [2,688](/filings/0001628280-26-054196.md) | [2,638](/filings/0001628280-26-031971.md) | [2,686](/filings/0001628280-26-054196.md) |
| Long-term debt | $m | [1,051](/filings/0000026324-23-000015.md) | [1,050](/filings/0000026324-25-000015.md) | [960](/filings/0000026324-24-000012.md) | [960](/filings/0000026324-24-000037.md) | [959](/filings/0000026324-24-000048.md) | [959](/filings/0001628280-26-007587.md) | [959](/filings/0000026324-25-000023.md) | [958](/filings/0001628280-25-038802.md) | [969](/filings/0001628280-25-050106.md) | [758](/filings/0001628280-26-054196.md) | [758](/filings/0001628280-26-031971.md) | [757](/filings/0001628280-26-054196.md) |
| Current portion of debt | $m | [0.0](/filings/0000026324-23-000015.md) | [0.0](/filings/0000026324-25-000015.md) | [90.0](/filings/0000026324-24-000012.md) | [90.0](/filings/0000026324-24-000037.md) | [90.0](/filings/0000026324-24-000048.md) | [90.0](/filings/0001628280-26-007587.md) | [0.0](/filings/0000026324-25-000023.md) | [0.0](/filings/0001628280-25-038802.md) | [0.0](/filings/0001628280-25-050106.md) | [200](/filings/0001628280-26-054196.md) | [200](/filings/0001628280-26-031971.md) | [200](/filings/0001628280-26-054196.md) |
| Shareholders' equity | $m | [2,185](/filings/0000026324-23-000015.md) | [2,328](/filings/0000026324-25-000015.md) | [2,380](/filings/0000026324-24-000012.md) | [2,458](/filings/0000026324-24-000037.md) | [2,490](/filings/0000026324-24-000048.md) | [2,450](/filings/0001628280-26-007587.md) | [2,559](/filings/0000026324-25-000023.md) | [2,712](/filings/0001628280-25-038802.md) | [2,529](/filings/0001628280-25-050106.md) | [2,534](/filings/0001628280-26-054196.md) | [2,632](/filings/0001628280-26-031971.md) | [2,770](/filings/0001628280-26-054196.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [146 d](/filings/0000026324-24-000048.md) | [282 d](/filings/0001628280-26-007587.md) | [(45.6)](/filings/0000026324-25-000023.md) | [111 d](/filings/0001628280-25-038802.md) | [177 d](/filings/0001628280-25-050106.md) | [301 d](/filings/0001628280-26-007587.md) | [(38.8)](/filings/0001628280-26-031971.md) | [137 d](/filings/0001628280-26-054196.md) | [193 d](/filings/0001628280-25-050106.md) | [353 d](/filings/0001628280-26-007587.md) | [(5.7)](/filings/0001628280-26-031971.md) | [181 d](/filings/0001628280-26-054196.md) |
| Capital expenditure | $m | [9.4 d](/filings/0000026324-24-000048.md) | [12.6 d](/filings/0001628280-26-007587.md) | [12.1](/filings/0000026324-25-000023.md) | [11.1 d](/filings/0001628280-25-038802.md) | [14.6 d](/filings/0001628280-25-050106.md) | [23.3 d](/filings/0001628280-26-007587.md) | [15.8](/filings/0001628280-26-031971.md) | [19.4 d](/filings/0001628280-26-054196.md) | [16.9 d](/filings/0001628280-25-050106.md) | [37.6 d](/filings/0001628280-26-007587.md) | [11.8](/filings/0001628280-26-031971.md) | [29.5 d](/filings/0001628280-26-054196.md) |
| Dividends paid | $m | [7.7 d](/filings/0000026324-24-000048.md) | [15.3 d](/filings/0001628280-26-007587.md) | not reported | not reported | [8.0 d](/filings/0001628280-25-050106.md) | [15.9 d](/filings/0001628280-26-007587.md) | not reported | not reported | [9.0 d](/filings/0001628280-25-050106.md) | [17.8 d](/filings/0001628280-26-007587.md) | not reported | not reported |
| Share repurchases | $m | [13.0 d](/filings/0000026324-24-000048.md) | [12.8 d](/filings/0001628280-26-007587.md) | [12.2](/filings/0000026324-25-000023.md) | [12.6 d](/filings/0001628280-25-038802.md) | [113 d](/filings/0001628280-25-050106.md) | [112 d](/filings/0001628280-26-007587.md) | [14.3](/filings/0001628280-26-031971.md) | [20.8 d](/filings/0001628280-26-054196.md) | [290 d](/filings/0001628280-25-050106.md) | [140 d](/filings/0001628280-26-007587.md) | [14.5](/filings/0001628280-26-031971.md) | [14.7 d](/filings/0001628280-26-054196.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [38.6](/filings/0000026324-23-000015.md) | [38.5](/filings/0000026324-24-000012.md) | [38.6](/filings/0000026324-24-000037.md) | [38.6](/filings/0000026324-24-000048.md) | [38.4](/filings/0000026324-25-000023.md) | [38.5](/filings/0001628280-25-038802.md) | [38.5](/filings/0001628280-25-050106.md) | [37.9](/filings/0001628280-26-031971.md) | [37.9](/filings/0001628280-26-054196.md) | [37.7](/filings/0001628280-25-050106.md) | [37.1](/filings/0001628280-26-031971.md) | [37.1](/filings/0001628280-26-054196.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 36,934,444 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001628280-26-054196.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.